Interestingly, a downregulation of CCS has been reported in several AD models, which diminishes SOD1 activity and increases the expression of the enzyme β-secretase 1 involved in the amyloidogenic processing of the amyloid precursor protein (APP) [94,95,96,97]. This evidence concerns the gene CCS and Alzheimer disease.